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INTRODUCTION
Although the incidence rate of IBD in Asian countries 
is considerably lower than the rate in Western countries, 
the burden of IBD has been rapidly increasing in Korea.1-3 
However, public awareness about IBD is still low in Korea. 
Delay in the diagnosis of IBD could delay therapy, which can 
worsen the outcome.4-7 
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Background/Aims: Inflammatory bowel disease (IBD) is a chronic disabling gastrointestinal disorder that diminishes the 
quality of life of the affected individuals. Limited data are available regarding the impact of IBD on the daily life of Koreans. 
Methods: Self-administered, computer-aided, internet-based questionnaires were distributed to members of a Korean patient 
organization for IBD from March to April 2013, by the Korean Association for the Study of Intestinal Diseases. Results: A total 
of 599 patients with IBD (387 with Crohn’s disease [CD] and 212 with ulcerative colitis [UC]) were enrolled. The majority of pa-
tients (81%) expressed feelings of fatigue, weakness, and being worn out in their daily lives during times of flare; this percentage 
was reduced to 61% during remission. Respondents were absent from work or school for an average period of 18 days because 
of illness, within the first 6 months; the majority of respondents (64%) felt stressed about their absence. Forty-six percent of the 
respondents reported having received unfair comments at work, or having suffered discrimination. Forty-seven percent of the 
respondents felt that IBD had negatively affected their income and earnings. Compared with patients with UC, those with CD 
reported a more frequent negative impact of IBD on work, or more economic burden. More than half of the respondents (61%) 
reported that IBD had prevented them from making or keeping friends. Conclusions: IBD significantly impacts daily life, in-
cluding work, education, and social relationships. Treatment that addresses the full spectrum of life of a patient would be more 
effective. (Intest Res 2017;15:338-344)
Key Words: Inflammatory bowel disease; Crohn disease; Colitis, ulcerative; Quality of life; Surveys and questionnaires
Received April 11, 2016. Revised August 7, 2016.  
Accepted August 8, 2016. Published online May 29, 2017
Correspondence to Sung-Ae Jung, Department of Internal Medicine, Ewha 
Womans University School of Medicine, 1071 Anyangcheon-ro, Yangcheon-
gu, Seoul 07985, Korea.  Tel: +82-2-2650-5053, Fax: +82-2-2655-2076, 
E-mail: jassa@ewha.ac.kr
Financial support: None.  Conflict of interest: None.
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년>
339www.irjournal.org
https://doi.org/10.5217/ir.2017.15.3.338 • Intest Res 2017;15(3):338-344
IBD mainly consists of UC and CD. These are chronic 
disabling gastrointestinal disorders that diminish the qual-
ity of life (QOL) of the patient.5,8-10 Patients with IBD more 
frequently receive disability allowances than those received 
by age-matched individuals from the general population,5,6,10 
which proves the detrimental effects of IBD on health-
related QOL and productivity.5,8 A recent large-scale study 
(comprising 4,670 patients with IBD from 25 countries) con-
ducted by the European Federation of Crohn’s and Ulcer-
ative Colitis Associations (EFCCA) reported the detrimental 
effects of IBD on intimate relationships, and the unfair com-
ments received by the patients with regard to their work per-
formance.8 
However, limited studies have assessed the impact of IBD 
on the life of patients in Korea, with the majority of studies 
having been conducted in Western cohorts.5,6,8-10 In addition, 
there is little public knowledge regarding IBD and the chron-
ic suffering of patients in Korea. 
To overcome these issues, the Korean Association for the 
Study of Intestinal Diseases (KASID) has been conducting 
the “Happy Bowel Campaign” since 2013 to raise public 
awareness of IBD in general and to provide accurate infor-
mation regarding the importance of early diagnosis and 
proper treatment to patients with IBD. In addition, the KA-
SID is a promoter of World IBD Day, held every year on May 
19.
This study reports the findings of a KASID-sponsored sur-
vey that aimed to investigate the impact of IBD on the daily 
lives of patients in Korea.
METHODS
1. Study Population
Patients with UC or CD were enrolled. Self-administered, 
computer-aided, internet-based questionnaires were dis-
tributed to them by the KASID, from March to April 2013. 
The KASID advertised the study through the Korean IBD 
patient advocacy and support group newsletter and website, 
and through online advertisements during the Happy Bowel 
Campaign. The purpose of the study was explained to pa-
tients at the time of enrollment. The survey was anonymous 
and the data were analyzed without revealing the personal 
details of the patients. Patients who had no Internet access 
were excluded, since the survey was only available online. 
Responding to the survey questions was considered consent 
to participate. 
2. Survey
The survey was designed by KASID members of the In-
ternational Affairs Committee Secretary of Liaison & Public 
Relations in cooperation with a communications company 
“Communication Works.” The survey was based primarily 
on the IMPACT survey of the EFCCA and on previously pub-
lished reports8 on the QOL of patients with IBD. The survey 
consisted of 68 questions divided into 6 categories: (1) de-
mographics, (2) experience with IBD, (3) overall impact on 
life, (4) overall impact on work, (5) overall economic impact, 
and (6) impact on relationships (Supplementary Material 1). 
Some questions regarding “flare” and “remission” were 
short-answer questions. Most questions were closed ended, 
and participants were allowed to select one applicable op-
tion. The extent of “flare” and “remission” was open to patient 
interpretation. The questions concerning the overall impact 
of IBD were measured using a 5-point Likert scale (strongly 
agree, 5; agree, 4; neither agree nor disagree, 3; disagree, 2; 
strongly disagree, 1). In these cases, disagree or strongly dis-
agree represented “no” and the other responses represented 
“yes.”
3. Statistical Analysis
The collected data were analyzed using SPSS for Windows 
version 22.0 statistical software (IBM Corp., Armonk, NY, 
USA). With regard to statistical accuracy, a range of ±2.53% 
(95% CI limits) was set. Descriptive statistics and multiple 
linear regression analysis were used to analyze the respons-
es, with subanalyses of patients with CD and UC. Subgroup 
differences were calculated using the chi-square test. 
4. Ethics
The study was approved by the Seoul National Univer-
sity Ethics Committee (number: E-1403-037-563), with the 
completion and return of the survey implying consent to 
participate.
RESULTS
1. Demographics
A total of 599 patients with IBD (387 [64.6%] with CD and 
212 [35.4%] with UC) completed the survey. Demographic 
and baseline data for all respondents are shown in Fig. 1. 
The majority of respondents were male (69.6%) in both the 
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CD and UC subgroups. The majority of participants (59%) 
reported a period of more than 5 years since the diagnosis of 
IBD (60% of the patients in the CD subgroup and 57% of the 
patients in the UC subgroup). 
2. Experience with IBD
Most respondents (84%) from the CD and UC groups re-
ported IBD being chronically active, whereas 16% reported 
being in remission. Sixty-five percent of the patients had 
been admitted to a hospital for IBD within the 5 years pre-
ceding the study; however, the proportion of patients with 
CD was significantly higher than the proportion of patients 
with UC (76%, P <0.001), with regard to the hospitalization. 
Thirty-eight percent of the patients received emergency care 
before being diagnosed with IBD. Eighteen percent of the 
respondents had experienced a surgical procedure because 
of IBD. More patients with CD than with UC reported this 
experience (P<0.001) (Table 1).
Forty-one percent of the respondents reported visiting 
a hospital 6 months after they noticed the first symptoms 
related to IBD. The time before the first hospital visit was sig-
nificantly longer in patients with CD (P<0.001). The reasons 
for delayed hospital visit were lack of knowledge about IBD 
(75%), mild symptoms (13%), inconvenient hospital access 
(3%), economic burden (3%), and others (6%). Most respon-
dents (75%) received a final diagnosis within a year after 
they first noticed the symptoms. The other 25% patients re-
ceived a final diagnosis after more than a year; in 3% of these, 
IBD was diagnosed after 5 years from their first symptoms. 
The time required for final diagnosis was also significantly 
longer in patients with CD (P<0.001) (Table 1). 
About three-quarters of the respondents reported un-
dergoing current treatment by a gastroenterologist (75%), 
while 13% reported undergoing current treatment by a 
primary physician. The most commonly taken drug among 
the respondents was 5-aminosalicylates (69%), followed by 
immunosuppressive agents (48%), corticosteroids (15%), 
and biological drugs (11%). More patients with CD than with 
UC were being treated with biological drugs (15% and 5%, 
respectively) at the time of conducting the study. Sixty-one 
Table 1. Experience with IBD 
CD (n=387) UC (n=212) P-value
Current status of IBD
     Chronically active condition 325 (84) 178 (84) 1.000
     In remission 62 (16) 34 (16) 1.000
Hospitalization in the past 5 yr 294 (76) 98 (46) <0.001
Emergency care before diagnosis of IBD 186 (48) 40 (19) <0.001
Previous surgeries owing to IBD 190 (49) 13 (6) <0.001
Time to hospital visit since noticing first symptoms (mo)
     <6 208 (54) 145 (68) <0.001
     ≥6 179 (46) 67 (32) <0.001
Time required to receive the final diagnosis since noticing the first symptoms (mo)
     <6 199 (51) 144 (68) <0.001
     6–12 77 (20) 29 (14) 0.058
     >12 112 (29) 38 (18) 0.003
Values are presented as number (%).
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Fig. 1. Baseline characteristics of patients with IBD. aP<0.05, compared 
with patients with UC.
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percent of the patients had experienced side effects from 
corticosteroids, and 87% of the patients were concerned 
about the long-term effects of corticosteroids.
3. Overall Impact of IBD on Life
The majority of patients (81%) expressed feelings of 
fatigue, weakness, and being worn out in their daily lives 
during times of flare; this percentage was reduced to 61% 
during remission. Most patients (68%) felt stressed and were 
psychologically affected even during remission. Thirty-seven 
percent of the patients reported that they felt like commit-
ting suicide (CD 41% vs. UC 30%, P =0.01). Multiple linear 
regression analysis revealed that previous emergency care 
(P=0.021), previous hospitalizations (P=0.036), previous sur-
geries (P =0.035), experience of abdominal pain (P=0.008), 
and using biologics (P =0.020) were associated with the 
feeling of committing suicide. Most patients (74%) were 
anxious about their future (Table 2). Young age (P =0.047), 
low income (P =0.026), and experience of abdominal pain 
(P<0.001) were associated with anxiety about the future, as 
per multivariable regression analysis.
4. Overall Impact of IBD on Work 
More than half (52%) of the respondents reported absence 
from work or school because of illness within the past 6 
months (mean, 18 days). Younger patients and patients with 
CD had had more sick days; the mean period absence ow-
ing to sickness was 10 days for those >40 years of age and 23 
days for those <40 years of age (P<0.001), and 20 days versus 
14 days for patients with CD and UC, respectively (P<0.001). 
The absence from work/school owing to IBD caused stress 
in 64% of the respondents. Compared to patients with UC, 
those with CD reported a more frequent negative impact of 
IBD on work (Table 3). The use of biologics (P =0.007) and 
steroids (P=0.001), previous hospitalization (P=0.043), previ-
ous surgeries (P=0.009), and abdominal pain (P=0.001) were 
associated with the negative impact of IBD on work, as per 
multiple linear regression analysis.
5. Overall Economic Impact of IBD
Forty-one percent of the respondents reported decreased 
QOL owing to the economic burden caused by IBD. Twenty-
one percent of the respondents had stopped medical treat-
Table 2. Overall Impact of IBD  on Daily Life 
CD (n=387) UC (n=212) P-value
Felt tired, weak, and worn out in daily life during flare-ups 311 (80) 174 (81) 0.664
Felt tired, weak, and worn out in daily life during remission 238 (61) 127 (60) 0.727
Felt stressed and psychologically affected during remission 270 (69) 137 (64) 0.201
Having felt like committing suicide 158 (41)   64 (30) 0.010
Having felt anxiety about the future 302 (78) 141 (67) 0.003
Values are presented as number (%).
Table 3. Overall Impact of IBD on Work 
CD (n=387) UC (n=212) P-value
Cancelled or rescheduled an appointment 238 (62) 121 (57) 0.297
Left office or school early 220 (57) 80 (38) <0.001
Absence from work or school 228 (59) 83 (39) <0.001
Felt stress about taking time off work or school 271 (70) 112 (53) <0.001
Received unfair comments at work or school 155 (40) 52 (25) <0.001
Suffered discrimination or were ostracized 52 (14) 14 (7) 0.010
Decline in income or academic ability 200 (52) 80 (38) 0.010
Unable to perform to their full potential 252 (66) 119 (56) 0.035
Values are presented as number (%).
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ment because of the economic burden. Those with CD 
reported an economic burden more often than those with 
UC (Table 4). Male gender (P=0.001), old age (P=0.011), low 
income (P =0.008), use of steroids (P =0.039) and biologics 
(P=0.023), previous hospitalization (P=0.048), and previous 
surgeries (P =0.002) were associated with high economic 
burden, as per multivariable regression analysis.
6. Impact of IBD on Relationships
Sixty-one percent of the patients reported that IBD had 
prevented them from making or keeping friends. Nearly half 
of the respondents (47%) reported having had to end an 
intimate relationship owing to IBD. Most of the respondents 
(70%) reported that the patient association had a beneficial 
impact on their life (Table 5). Young age (P=0.002), previous 
surgeries (P=0.003), and previous hospitalization (P=0.038) 
were associated with the negative impact of IBD on relation-
ships, as per multivariable regression analysis.
DISCUSSION
IBD is typically diagnosed in childhood or early adulthood, 
and is a lifelong condition.5,8-10 Although IBD does not reduce 
life expectancy, it has a substantial impact on health-related 
QOL.8,11,12 The present study reports the experience of IBD 
among Korean patients and the impact of IBD on their daily 
life. Most patients with IBD were tired, weak and worn out 
in their daily life during a remission as well as during flare-
ups. A large number of patients reported that IBD adversely 
affected their QOL. This negative impact of IBD was more 
severe in patients with CD than in those with UC. A previous 
experience of surgeries, and hospitalization due to IBD were 
associated with this negative impact. In general, chronic fa-
tigue has been found to be more prevalent in patients with 
IBD than in healthy subjects,9,13,14 which, in turn, diminishes 
the health-related QOL in IBD.9 Accordingly, physicians 
should remember that fatigue is an important symptom of 
IBD that impacts the health-related QOL of the patients.
In this study, the time from onset of symptoms of IBD to 
hospital visit was long; over 41% of the patients had been 
symptomatic for at least 6 months before visiting a clinician. 
The most common cause of delayed hospital visit was lack of 
patient’s knowledge about the disease. In addition, although 
most responders reported establishment of a final diagnosis 
within 12 months after noticing the first symptoms, 25% of 
the patients waited for more than a year for the final diagno-
sis. The delay in meeting a specialist and emergency depart-
ment visit was more striking for patients with CD than for 
those with UC. Population-based cohort studies reported 
that one-fifth to one-third of the patients with CD have 
complications such as stricture, abscess and/or fistula at the 
time of diagnosis.15,16 Functional gastrointestinal disorders 
such as IBS often mimic early manifestations of IBD, and 
infectious diseases such as intestinal tuberculosis, which 
mimic IBD, can hinder accurate assessment of the disease 
Table 4. Overall Economic Impact of IBD 
CD (n=387) UC (n=212) P-value
Stopped medical treatment owing to economic burden 96 (25) 30 (14) 0.002
IBD had negatively affected the income 201 (52) 180 (38) <0.001
Sorry for the family bearing treatment cost 244 (63) 79 (37) <0.001
Decreased quality of life owing to the economic burden 170 (44) 77 (36) 0.082
Values are presented as number (%).
Table 5. Impact of IBD on Relationships 
CD (n=387) UC (n=212) P-value
Prevented from making or keeping friends 237 (62) 126 (59) 0.663
Had to end an intimate relationship end owing to IBD 182 (47) 100 (47) 1.000
Felt stressed about keeping intimate family relationships 155 (40) 85 (40) 1.000
Meeting others with IBD made them more optimistic 120 (31) 67 (32) 0.927
Patient association had a beneficial impact on their life 258 (67) 161 (76) 0.020
Values are presented as number (%).
https://doi.org/10.5217/ir.<년>.<년>.<년>.<년년년년년> • Intest Res <년>;<년>(<년>):<년년년년년>-<년년년년>
343www.irjournal.org
https://doi.org/10.5217/ir.2017.15.3.338 • Intest Res 2017;15(3):338-344
in Korea, thereby delaying hospital visit or referral to IBD 
specialists.7,17,18 In the IMPACT survey, only 54% of the 4,670 
patients received a final diagnosis within 1 year after notic-
ing the first symptoms. About 20% of the patients received 
a final diagnosis after more than 5 years. The majority of 
patients (67%) had visited an emergency department at least 
once before their diagnosis.8 Timely diagnosis and treat-
ment would help reduce the health care burden of hospitals, 
including prediagnosis hospital visits or admissions.8,19 Pa-
tients with IBD tend to require emergency room or primary 
clinic care prior to diagnosis; thus, awareness about IBD is 
necessary among emergency care staff or primary physi-
cians.8
About 15% of the respondents received corticosteroid 
therapy, which was a concern for most of them. Corticoste-
roid use should be consistent with the guidelines, and the 
advantages and possible detrimental effects should be dis-
cussed with patients.8,20-22
The fluctuations and unpredictable exacerbations of IBD 
symptoms have a significant psychological impact on the 
patient’s life. Fears related to the long-term effects of treat-
ments, and the progression of the disease can exacerbate 
anxiety and depression.11,23-25 In the present study, 37% of the 
patients reported having felt like committing suicide. Most 
patients were anxious about their future. The prevalence 
of anxiety and/or depression in patients with IBD has been 
reported to be 35% during remission;24 the prevalence of 
anxiety and depression during relapse has been reported 
to be 80% and 60%, respectively.25 In a recent study, Korean 
patients with IBD showed higher levels of depression and 
impaired health-related QOL than those shown by healthy 
controls.26 The negative perceptions of IBD among patients 
and the depressive mood can increase treatment nonadher-
ence, leading to a poorer outcome.19 Integrating psycho-
logical interventions with conventional medical treatment 
seems prudent.11 
IBD had a considerable impact on work and economic 
burden in the present study. Many patients, especially young 
respondents and those with CD, had missed school or work 
in the 6 months prior to the study, consistent with other 
reports,8,27 which, for many patients, is a source of stress 
and can be the basis for hurtful comments or employment 
problems. Accordingly, medical discussions should consider 
work and economic burden as important facets of treatment 
among Korean patients with IBD. 
With regard to building human relationships, IBD can lead 
to decreased physical intimacy and social activity.28,29 Be-
ing able to talk about IBD-related problems in a supportive 
group setting was helpful for many respondents, as was the 
awareness created by health care professionals regarding 
the influence of IBD on these aspects of life. 
This study had several limitations. Firstly, the survey was 
a self-completed instrument and was only available online, 
so individuals without Internet access could not participate. 
Thus, the results cannot be generalized to the entire popula-
tion. Secondly, the survey questionnaire was not validated. 
Finally, self-assessment introduces the possibility of recall 
bias concerning aspects such as medication use and emer-
gency care. Some patients might have overestimated the 
negative impact of IBD on their lives.
Despite the limitations, our study is meaningful because 
it is the first large-scale study to investigate the effects on 
IBD on the daily life of Korean patients. The results would 
be valuable in devising strategies of care, and campaigns to 
increase the awareness of IBD in Korea. 
In conclusion, IBD considerably affects the daily life of the 
patients, including their work, school, and social relation-
ships. Treatment that addresses that full spectrum of a pa-
tient’s life would be more effective. 
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Supplementary Material 1. A Survey of Patients with Inflammatory Bowel Disease (IBD)
Demographics
Sex 1. Male       2. Female
Age ① Less than 10 years [<10 years]  
② 10~19 years 
③ 20~24 years 
④ 25~29 years 
⑤ 30~34 years 
⑥ 35~39 years 
⑦ 40~44 years  
⑧ 45~49 years  
⑨ 50~54 years 
⑩ 55~59 years 
⑪ 60~64 years 
⑫ >65 years 
Marital status ① Single       ② Married
With or without children ① Have a child (ⓐ one (child)  ⓑ two (children)  ⓒ three (children)  ⓓ four (children)  ⓔ Other (   children))   
② No children
Occupation ① Student  
② Company employee (office job, technical job) 
③ Business administrative position 
④ Professional freelancer 
⑤ Private business 
⑥ Sales and service
⑦ Simple labor/technical officer/ production 
⑧ Agriculture / Forestry / Fisheries 
⑨ Housewife 
⑩ Unemployed
⑪ Other (     )
Average monthly  
income (household)
① <2,000,000 won 
② 2,000,000~2,490,000 won  
③ 2,500,000~2,990,000 won 
④ 3,000,000~3,490,000 won 
⑤ 3,500,000~3,990,000 won 
⑥ 4,000,000~4,490,000 won 
⑦ 4,500,000~4,990,000 won 
⑧ 5,000,000~6,990,000 won 
⑨ 7,000,000~9,990,000 won 
⑩ ≥10,000,000 won 
Occupied area ① Seoul 
② Metropolitan City (Busan, Gwangju, Daegu, Daejeon, Incheon, Ulsan) 
③ City 
④ Town  
⑤ Other (       )
Society membership status ① The Crohn’s Family Lovers Committee
② UC Lovers Committee 
③ Other (                     ) 
④ Not joined
See “Impact of inflammatory bowel disease on daily life: an online survey by the Korean Association for the Study of Intesti-
nal Diseases” on page 338.
• Which disease of IBD are you diagnosed?
① Corhn’s disease (CD)      ② Ulcerative colitis (UC)      ③ Other (  )
• Which is a period of the applicable disease? 
① 2 years      ② 2-5 years      ③ 5-10 years      ④ >10 years
• Which is the current treatment drug/therapeutic measures? 
① Steroids      ② 5 ASA (asacol( ) pentasa( ) salofalk( ) zopyrin( ))
③ Salazine      ④ Colazal      ⑤ Immunomodulator      ⑥ Biologics      ⑦ Probiotics
Experience with IBD - Disease Diagnosis and Current Status
1. When did you experience the symptoms of IBD first? 
① 1 year or less      ② 1-3 years ago      ③ 4-5 years ago      ④ 6~7 years ago      ⑤ 7~9 years ago      ⑥ over 10 years ago 
2. When did you visit a hospital due to IBD after you experienced first symptom?  
① within 1 month   
② 1~3 months 
③ 3~6 months  
④ 6 month~1 year
⑤ 1 year~2year 
⑥ 2~5 years 
⑦ over 5 years 
2-1. Why you visited a hospital after a year passed since you have experienced symptom?  
① Because symptoms were not severe 
② Did not notice disease  
③ Have no time 
④ Could not afford it financially 
⑤ Have difficulty in visiting a hospital and getting a diagnosis 
⑥ Did not know which hospital I should visit 
⑦ Other (             )
3. How long did it take to get final IBD diagnosis through a health care professional since you noticed first symptoms? 
① < 3 months      ② 3~6 months      ③ 6 months ~ 1 year      ④ 1~2 years      ⑤ 2~5 years      ⑥ ≥ 5 years
4. Have you ever visited the emergency room because of emergency situations caused by IBD before you got diagnosed? If so, how many times did 
you visit? 
① Yes (       times)      ② No
5. Which is the current status of IBD?
① Asymptomatic status      ② Have symptoms, but they are controlled by medicine      ③ Status that symptoms are changed for the better or worse 
6. Have you ever hospitalized in the past 5 years? If so, when? 
① Yes (ⓐ 2013  ⓑ 2012  ⓒ 2011  ⓓ 2010  ⓔ 2009  ⓕ 2008) 
② No
7. Have you ever experienced a surgery before due to IBD? 
① Yes (ⓐ one time  ⓑ two times  ⓒ three times  ⓓ four times  ⓔ 5 or more times)
② No
8. Do you have any other systemic associated disease besides IBD? 
① Yes, I have. (ⓐ rheumatoid arthritis  ⓑ ankylosing spondylitis  ⓒ psoriasis)   
② No, I don’t have.
9. Have you ever experience cramps or abdominal pain? How many days you usually experience per one week? 
① Yes, I have (ⓐ one day  ⓑ two days  ⓒ three days  ⓓ four days  ⓔ five days  ⓕ six days  ⓖ everyday)  
② No, I haven’t
10. Have you had a sudden diarrhea that cannot be tolerated within recent 6 months? How many days you usually experience it? 
① Yes, I have (ⓐ one day  ⓑ two days ⓒ three days  ⓓ four days  ⓔ five days  ⓕ six days  ⓖ every day) 
② No, I don’t have
11. How about your status when there are bad symptoms or no symptoms? 
Very often Often Sometimes Rarely Never
11-1 Felt tired, weak and worn out in daily life during flare up 5 4 3 2 1
11-2 Felt tired, weak and worn out in daily life during remission 5 4 3 2 1
11-3 Felt stressed and affected psychologically during remission 5 4 3 2 1
Treatments
12. Are you meeting health care professionals currently because of IBD? Please choose those you are meeting. 
① Yes ① Primary hospitals/ clinics doctor (ⓐ internal medicine  ⓑ family physician  ⓒ surgery department  ⓓ proctological surgery center 
ⓔ neuropsychiatry department  ⓕ pediatric department) 
② General hospital specialist (ⓐ gastroenterologist  ⓑ anorectal surgeon  ⓒ rheumatologist  ⓓ psychiatrist) 
③ Public health center 
④ Oriental medicine clinic 
⑤ Psychologist  
② No
13. Have you received steroid medication or are you receiving steroid medication? What do you think about drug effects?
Yes No
13-1 Have used steroids for the last 1 year for the relaxation of IBD symptoms 1 2
13-2 Kept using steroids at the time of severe symptoms 1 2
Very often Often Sometimes Rarely Never
13-3 Worried about the effects of long-term effects of steroids on my health 5 4 3 2 1
13-4 Experience side effects 5 4 3 2 1
Impacts of IBD on Daily Life - Impact on Relationship
14. Do you think that IBD prevents from keeping relationship maintenance / consolidation with acquaintance or relationship formation with new 
people?   
Very often Often Sometimes Rarely Never
14-1 Prevented from making or keeping friends 5 4 3 2 1
14-2 Had an intimate relationship wane or end due to their IBD 5 4 3 2 1
14-3 Felt stress about keeping an intimate family relationship 5 4 3 2 1
14-4 Meeting others with IBD made them more optimistic 5 4 3 2 1
14-5 Patient’s association had beneficial impact on their life 5 4 3 2 1
Work Impact 
15. Overall work impact of inflammatory bowel disease
Very often Often Sometimes Rarely Never
15-1 Cancelled or rescheduled an appointment 5 4 3 2 1
15-2 Left school or office early 5 4 3 2 1
15-3 Absence from school or work 5 4 3 2 1
15-4 Took time off from school or work 5 4 3 2 1
15-5 Felt stress about taking time off work or school 5 4 3 2 1
15-6 Received unfair comments at work or school 5 4 3 2 1
15-7 Suffered discrimination or being ostracized 5 4 3 2 1
15-8 Decline in income or academic ability 5 4 3 2 1
15-9 Unable to perform their full potential 5 4 3 2 1
16. What is the number of days which is absent from school or work or left on vacation within recent 6 months? 
(Total      day(s))
Economic Impact 
17. How much money do you spend per one month for the treatment of IBD? 
① 50 million won or less      ② 50~100 million won      ③ 100~200 million won      ④ 200 million or more
18. To what extent is IBD likely to affect your finance? 
Very often Often Sometimes Rarely Never
18-1 Stopped medical treatment due to economic burden  5 4 3 2 1
18-2 Felt sorry for my family bearing treatment cost 5 4 3 2 1
18-3 The quality of life had decreased due to economic burden. 5 4 3 2 1
18-4 Having felt like committing suicide 5 4 3 2 1
18-5 Having felt anxiety about the future 5 4 3 2 1
Pregnancy 
19. To what extent is IBD likely to affect your pregnancy, childbirth, and parenting? 
*Please indicate your experience or thoughts about pregnancy and childbirth. Very often Often Sometimes Rarely Never
19-1 Did not want marry (because of having guilty of spouse) 5 4 3 2 1
19-2 Did not want to get pregnant 5 4 3 2 1
19-3 Did not want to get pregnant with a fear of harming babies. 
(Miscarriage, fetal deformities, and premature birth, etc.)
5 4 3 2 1
19-4 Did not want to get pregnant with a fear that my disease might be 
aggravated
5 4 3 2 1
19-5 I am afraid that my disease is passed down to my children. 5 4 3 2 1
19-6 Stopped medication for breastfeeding (I think I should stop it.) 5 4 3 2 1
19-7 My child is healthy. 5 4 3 2 1
19-8 Had to stop all drugs during pregnancy (I think taking therapeutic 
medicines should be stopped during pregnancy.) 
5 4 3 2 1
19-9 Stopped breast feeding (I thought that I should stop it) 5 4 3 2 1
Expectation / Requirement for Disease Diagnosis / Treatment Environment
20. Which is the most expectation from IBD treatment / management? Please pick up the most three important things in the ranking order. 
1st place (      ), 2nd place (      ), 3rd place (      )
① Treatment with few side effects 
② Treatment for the fast relief of symptom 
③ Treatment with less time charge such as visit to hospital etc. 
④ Treatment with less economic burden 
⑤ Treatment that is effective in associated disease prevention / treatment 
⑥ Other (           )
21. What do you think about the treatment / management environment improvement / development of the inflammatory bowel disease (IBD)? 
Strongly 
agree Agree Neutral Disagree
Strongly 
disagree
21-1 Hope that the government support for IBD treatment expenses will be 
expanded
5 4 3 2 1
21-2 Hope that the government support for IBD diagnosis expenses will be 
expanded
5 4 3 2 1
21-3 Hope that the government support for IBD-related auxiliary treatment 
(such as probiotics etc.) will be expanded
5 4 3 2 1
21-4 Hope that efforts will be made to alleviate prejudice and misconceptions 
against IBD patients and increase related awareness
5 4 3 2 1
Disease-related Information Acquisition 
22. Please tell us how to get information about inflammatory bowel disease (IBD) in the ranking order. 
1st place (           ), 2nd place(                ), 3rd place (          ) 
① Doctor / Heath care professional   
② Patient group 
③ Acquaintance 
④ TV broadcasting 
⑤ Radio broadcasting 
⑥ Newspaper
⑦ Magazine
⑧ Website (Government / Society operation) 
⑨ Internet search engine 
⑩ Promotions such as hospital / pharmaceutical brochure 
⑪ Other (        )
23.  Tell us what you want to know inflammatory bowel disease (IBD) specifically. 
(                                                               )
